Iain Stuart - 31 Mar 2025 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Mutya Harsch, Attorney-in-Fact
Issuer symbol
VYNE
Transactions as of
31 Mar 2025
Net transactions value
-$9,550
Form type
4
Filing time
02 Apr 2025, 16:15:20 UTC
Previous filing
23 Jan 2025
Next filing
02 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $9,550 -6,044 -4.7% $1.58 122,593 31 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.